Novartis Exelon Promotion Cited By FDA For Unsubstantiated Superiority Claims To Aricept
Professional file card for the Alzheimer's medication is misleading because it is based on an inadequate study, FDA warning letter says.
Professional file card for the Alzheimer's medication is misleading because it is based on an inadequate study, FDA warning letter says.